Rosen Michel de's Net Worth
$2.95 Million
Who is Rosen Michel de?
Rosen Michel de has an estimated net worth of $2.95 Million. This is based on reported shares across multiple companies, which include DBV Technologies S.A., ENDO PHARMACEUTICALS HOLDINGS INC, and VIROPHARMA INC.
SEC CIK
Rosen Michel de's CIK is 0001187148
Past Insider Trading and Trends
2005 was Rosen Michel de's most active year for acquiring shares with 11 total transactions. Rosen Michel de's most active month to acquire stocks was the month of April. 2008 was Rosen Michel de's most active year for disposing of shares, totalling 3 transactions. Rosen Michel de's most active month to dispose stocks was the month of August. 2004 saw Rosen Michel de paying a total of $542,000.00 for 200,000 shares, this is the most they've acquired in one year. In 2008 Rosen Michel de cashed out on 337,577 shares for a total of $3,653,420.93, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DBV Technologies S.A. (DBVT) Snapshot price: $0.8701
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENDO PHARMACEUTICALS HOLDINGS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.00% | 155 |
—
|
—
| 5.32K |
Jun 30
| |||
Form 4
| +3.14% | 157 |
—
|
—
| 5.16K |
Mar 31
| |||
Form 4
| +121.18% | 2.74K |
—
|
—
| 5K |
Mar 12
| |||
Form 4
|
∞
| 2.26K |
—
|
—
| 2.26K |
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VIROPHARMA INC No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -68.68% | -300.68K |
$12.15 | -$3,653,420.93 | 137.1K |
Nov 7 - Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| +9.20% | 36.9K |
$2.71 | $99,999.00 | 437.78K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| +10.92% | 39.48K |
$2.53 | $100,005.81 | 400.88K |
Sep 4
| |||
Form 4
| +3.47% | 12.12K |
$8.17 | $99,020.40 | 361.4K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
| +2.98% | 10.1K |
$9.84 | $99,425.59 | 349.28K |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| +3.20% | 10.53K |
$19.88 | $209,309.70 | 339.18K |
Dec 13 - Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +9.50% | 28.5K |
$3.51 | $99,899.40 | 328.65K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||